With no enf in sight to the rise in number of covid cases, the insurance regulator has modified its earlier guidelines for corona-specific products and allowed renewal, migration as well as portability of such products.
Initially, the regulator had said, lifelong renewability, migration and portability are not applicable to such products.
However, it has now tweaked the guidelines and has allowed ‘Corona Kavach’ and ‘Corona Rakshak’ policies of any tenure to be renewed for further terms of three-and-a-half months, six-and-a-half months or nine-and-a-half months as per the option exercised by the policyholder. However, the renewal shall be subject to the underwriting policy of the insurer.
Also, the renewal has to be done before the expiry of the existing policy contract. Hence, these policies have been allowed by the regulator to be renewed till 31st March,2021.
Furthermore, on renewal, there will be no additional waiting period of 15 days and the policy coverage will continue seamlessly. And during renewal, sum insured can also be changed by the policyholders. But if there is an increase in the sum insured, the waiting period shall start afresh only for the enhanced portion of the sum insured, the regulator said.
As far as migration is concerned, for Corona Kavach policies, insurers have the choice to offer migration to any other indemnity based health insurance product offered by them as per the option exercised by the policyholder.
ALSO READ: As Covid-19 upends traditional functioning, insurance goes digital
Further, in case of group policies, insurers can provide migration to the members insured to any other individual indemnity based health policy at the point of exit of the member insured from the group policy or the cessation of coverage of the underlying group policy.
The regulator has said, in case migration is allowed, the accrued gains of waiting period served in the existing Corona Kavach policy, be it in individual or group policies, should be protected. It has also asked the insurers to allow portability of Corona Kavach (individual) policy from one insurer to another.
“The accrued gains of waiting period served in the existing Corona Kavach policy shall be protected in respect of coverage of Covid-19, by the porting-in insurer”, the regulator said.
The Corona Kavach policy is an indemnity cover, with an optional cover that will be made available on a benefit basis. This indemnity cover takes care of hospitalisation expenses incurred by the insured for the treatment of Covid-19 on positive diagnosis. All costs relating to room, nursing expenses, medical consultation, including telemedicine, personal protective equipment kit, and intensive care unit, are covered under the policy. It also includes the cost of treatment for other co-morbidities, including pre-existing comorbid conditions along with the treatment for Covid-19.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.